ALK and neoplasm: Wild-type LUAD demonstrated a higher number of tumor-infiltrating CD8+ T-cells, while in tumors with EGFR and ALK alterations, the number of CD8+ T-cells was much lower (Figure 3), and KRASm LUAD was heterogeneous in terms of tumor-infiltrating CD8+ cells count.